Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
History
Staff
Contact
Careers
Support The Mission
Support The Mission
Become a Member
Explore Different Ways to Give
Join IASLC's Partners for Thoracic Cancer Care
Recognizing Our Donors
Access Online Learning
Conferences & Education
Conferences & Education
Conferences
Webinars
Online Learning: Lung Cancer 360
Lung Cancer Considered Podcast
WCLC: World Conference on Lung Cancer
Science & Research
Science & Research
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Research Grant Program
Research Grant Program
Research Grant Recipients
IASLC Academy
Publications, Resources & Guidelines
Membership
Membership
Become a Member
Renew Your Membership
Early-Career Opportunities
Partners Society Membership Offers
Patients & Caregivers
Patients & Caregivers
STARS Training
Lung Cancer Awareness Month
News
News
IASLC Lung Cancer News
WCLC 2024 News
Press Releases
Search
Fulltext search
Fulltext search
Search
Displaying 1957 - 1968 items out of 2198 results
ILCN article
2024 IASLC Academy to Once Again Compete in Amazing Case Race
ILCN article
Get Moving and Win During the 2024 Wellness Challenge
ILCN article
Know Before You Go: What You Need to Know to Get to—and Navigate—San Diego
Podcast
IASLC's 50th Anniversary: The IASLC Today
Landing page
Conferences
Landing page
Conferences & Education
Resource
Staging Cards in Thoracic Oncology, 9th Edition
Podcast
IASLC's 50th Anniversary: The IASLC's Future
Press release
Datopotamab Deruxtecan Does Not Meet Its Secondary Primary Endpoint in TROPION-Lung01, But Researchers Believe Therapy is Still Beneficial for Some Patients with Non-Squamous NSCLC
Press release
Osimertinib With Savolitinib Demonstrates Stronger Efficacy Than Osimertinib Alone in Patients Who Do Not Respond Well to EGFR-TKIs Therapy
Press release
Zongertinib Demonstrates Promising Efficacy in Patients with HER2-Mutant NSCLC: Primary Phase Ib Analysis of Beamion LUNG-1
Press release
Breakthrough Therapy BAY 2927088 Demonstrates ‘Rapid, Substantial and Durable Responses’ in Patients with HER2-Mutant NSCLC
Pagination
First
First page
‹
Previous page
…
160
161
162
163
164
165
166
167
168
…
›
Next page
Last
Last page